Glimepiride Tablet
Product Images NDC 16571-773

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 16571-773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1 mg (100 Tablet Bottle))

Glimepiride Tablets, USP 1 mg oral tablets label by Rising Pharma Holdings, Inc. The label indicates a 100-tablet count, with a note to take once a day. It emphasizes storage at 20° to 25°C and includes warnings for child safety and pharmacist dispensing guidance. The product is made in India.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Tablet Bottle))

Label for Glimepiride Tablets, USP 2 mg oral tablets, distributed by Rising Pharma Holdings, Inc. The label states a package contains 100 tablets and is prescription-only. It includes storage instructions at 20° to 25°C, warnings to keep out of reach of children, and dispensing instructions for pharmacists about child-resistant containers. The label also shows the NDC 16571-774-01 and indicates the product is made in India.*

FDA Label Image

Package Label-principal Display Panel (4 mg (100 Tablet Bottle))

Label for Glimepiride Tablets USP 4 mg, oral tablets in a 100-tablet package by Rising Pharma Holdings, Inc. The label notes prescription only usage, dosage instructions to see package insert, storage conditions at 20° to 25°C, and child-resistant packaging requirements. Distributed by Rising Pharma Holdings, Inc., made in India, with barcode and coding area indicated.*

FDA Label Image

Chemical Structure (Glimepiride Str)

Chemical structure of Glimepiride, the active ingredient in the medication Glimepiride. The structure shows the molecular arrangement of atoms and bonds characteristic to Glimepiride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.